IL198704A - Pharmaceuticals and vaccines to treat cancer or infection - Google Patents
Pharmaceuticals and vaccines to treat cancer or infectionInfo
- Publication number
- IL198704A IL198704A IL198704A IL19870409A IL198704A IL 198704 A IL198704 A IL 198704A IL 198704 A IL198704 A IL 198704A IL 19870409 A IL19870409 A IL 19870409A IL 198704 A IL198704 A IL 198704A
- Authority
- IL
- Israel
- Prior art keywords
- vaccines
- tumor
- infection
- treating
- therapeutic compositions
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/26—Universal/off- the- shelf cellular immunotherapy; Allogenic cells or means to avoid rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Developmental Biology & Embryology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85850706P | 2006-11-13 | 2006-11-13 | |
US11/936,948 US7972594B2 (en) | 2006-11-13 | 2007-11-08 | Ablative immunotherapy |
PCT/US2007/023616 WO2008133651A2 (en) | 2006-11-13 | 2007-11-09 | Ablative immunotherapy |
Publications (2)
Publication Number | Publication Date |
---|---|
IL198704A0 IL198704A0 (en) | 2011-08-01 |
IL198704A true IL198704A (en) | 2015-06-30 |
Family
ID=39369457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL198704A IL198704A (en) | 2006-11-13 | 2009-05-12 | Pharmaceuticals and vaccines to treat cancer or infection |
Country Status (6)
Country | Link |
---|---|
US (4) | US7972594B2 (ja) |
EP (1) | EP2083845B1 (ja) |
JP (2) | JP5498792B2 (ja) |
CA (1) | CA2669315C (ja) |
IL (1) | IL198704A (ja) |
WO (1) | WO2008133651A2 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7435592B2 (en) | 2003-05-13 | 2008-10-14 | Immunovative Therapies, Ltd. | Compositions for allogeneic cell therapy |
US7972594B2 (en) | 2006-11-13 | 2011-07-05 | Immunovative Therapies Ltd. | Ablative immunotherapy |
US9320794B2 (en) | 2006-11-13 | 2016-04-26 | Immunovative Therapies, Ltd. | Ablative immunotherapy |
US8685416B2 (en) | 2010-03-02 | 2014-04-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Compositions and methods for the treatment of cancer |
SG184819A1 (en) * | 2010-04-13 | 2012-11-29 | Immunovative Therapies Ltd | Methods and compositions for inhibition of treg cells |
AU2012250807A1 (en) | 2011-05-03 | 2013-12-12 | Immunovative Therapies, Ltd. | Induction of IL-12 using immunotherapy |
CA2839196A1 (en) | 2011-06-15 | 2012-12-20 | Chrontech Pharma Ab | Injection needle and device |
WO2014164396A1 (en) * | 2013-03-12 | 2014-10-09 | Michael Har-Noy | Ablative immunotherapy |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996029394A1 (en) * | 1995-03-17 | 1996-09-26 | The Regents Of The University Of California | Method for treating tumors |
US5837251A (en) * | 1995-09-13 | 1998-11-17 | Fordham University | Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases |
US6277368B1 (en) | 1996-07-25 | 2001-08-21 | The Regents Of The University Of California | Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine |
AU743855B2 (en) * | 1996-10-11 | 2002-02-07 | Regents Of The University Of California, The | Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
US6797480B1 (en) * | 1998-10-05 | 2004-09-28 | University Of Connecticut Health Center | Purification of heat shock/stress protein cell surface receptors and their use as immunotherapeutic agents |
US6105775A (en) * | 1999-04-20 | 2000-08-22 | Pakon, Inc. | Sleeving system for photographic film negatives |
US6875849B2 (en) * | 2001-05-01 | 2005-04-05 | Arizona Board Of Regents Of Behalf Of The University Of Arizona | Methods of recovering chaperone proteins and complexes thereof |
US20030134415A1 (en) * | 2001-09-19 | 2003-07-17 | Gruenberg Micheal L. | Th1 cell adoptive immunotherapy |
JP2003321375A (ja) * | 2002-05-01 | 2003-11-11 | Toray Ind Inc | ヒトt細胞による肝疾患治療剤 |
US7435592B2 (en) * | 2003-05-13 | 2008-10-14 | Immunovative Therapies, Ltd. | Compositions for allogeneic cell therapy |
PT2573166T (pt) * | 2004-02-26 | 2016-07-07 | Immunovative Therapies Ltd | Métodos para preparar células-t para terapia celular |
US20050214268A1 (en) | 2004-03-25 | 2005-09-29 | Cavanagh William A Iii | Methods for treating tumors and cancerous tissues |
JP2008539751A (ja) * | 2005-05-10 | 2008-11-20 | アヴァリス・アーベー | 新規組成物およびその使用 |
CA2545557A1 (en) | 2005-05-31 | 2006-11-30 | Mcgill University | Stromal antigen-presenting cells and use thereof |
US20080112963A1 (en) | 2006-11-13 | 2008-05-15 | Immunovative Therapies, Ltd. | Ablative immunotherapy |
US7972594B2 (en) | 2006-11-13 | 2011-07-05 | Immunovative Therapies Ltd. | Ablative immunotherapy |
WO2009095033A1 (en) | 2008-01-31 | 2009-08-06 | Agirx Limited | Vaccine compositons |
-
2007
- 2007-11-08 US US11/936,948 patent/US7972594B2/en active Active
- 2007-11-09 JP JP2009536306A patent/JP5498792B2/ja active Active
- 2007-11-09 EP EP07874119.6A patent/EP2083845B1/en active Active
- 2007-11-09 CA CA2669315A patent/CA2669315C/en active Active
- 2007-11-09 WO PCT/US2007/023616 patent/WO2008133651A2/en active Application Filing
-
2009
- 2009-05-12 IL IL198704A patent/IL198704A/en active IP Right Grant
-
2011
- 2011-06-01 US US13/150,893 patent/US9272001B2/en active Active
-
2013
- 2013-05-17 JP JP2013104937A patent/JP2013155201A/ja not_active Withdrawn
-
2016
- 2016-01-21 US US15/003,437 patent/US11213576B2/en active Active
- 2016-01-21 US US15/003,447 patent/US11160852B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20160144010A1 (en) | 2016-05-26 |
US9272001B2 (en) | 2016-03-01 |
US20110229502A1 (en) | 2011-09-22 |
JP5498792B2 (ja) | 2014-05-21 |
EP2083845A2 (en) | 2009-08-05 |
JP2010509337A (ja) | 2010-03-25 |
JP2013155201A (ja) | 2013-08-15 |
CA2669315C (en) | 2017-12-12 |
WO2008133651A3 (en) | 2009-04-16 |
US11160852B2 (en) | 2021-11-02 |
CA2669315A1 (en) | 2008-11-06 |
WO2008133651A2 (en) | 2008-11-06 |
IL198704A0 (en) | 2011-08-01 |
EP2083845A4 (en) | 2011-08-24 |
US20080112975A1 (en) | 2008-05-15 |
US7972594B2 (en) | 2011-07-05 |
US20160136270A1 (en) | 2016-05-19 |
EP2083845B1 (en) | 2020-03-04 |
US11213576B2 (en) | 2022-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL291175A (en) | Compositions and methods for treating collagen-mediated diseases | |
GB0602178D0 (en) | Therapeutic treatment | |
EP1985302A4 (en) | DRUGS FOR TUMOR THERAPY AND ITS USE | |
ZA200804918B (en) | Therapeutic vaccine | |
IL198663A0 (en) | Tissue treatment methods | |
ZA200808485B (en) | Lyophilized therapeutic peptibody formulations | |
IL198704A0 (en) | Therapeutic compositions and vaccines for treating a tumor or infection | |
HUE044410T2 (hu) | Egydózisú anti-PCV2 sertés vakcina | |
IL198723A0 (en) | Methods and compositions for therapeutic treatment | |
GB0608655D0 (en) | Therapeutic Treatment | |
GB0718446D0 (en) | Compositions and methods for the treatment of infection | |
EP2140884A4 (en) | VACCINE FOR THE PREVENTION AND / OR TREATMENT OF AUTOIMMUNE DISEASES | |
GB0610909D0 (en) | Therapeutic treatment | |
EP2029156A4 (en) | POLY THERAPY FOR TREATING CANCER | |
EP1919490A4 (en) | MEDICAL PLANT COMPOSITION FOR THE TREATMENT OF INFECTIONS | |
EP1871166A4 (en) | VACCINES AGAINST CANCER AND THERAPEUTIC METHODS | |
EP2042188A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF HCV INFECTION | |
EP2005964A4 (en) | MEDICAMENT FOR TREATING HYPERPHOSPHATEEMIA AND PREPARATION METHOD THEREOF | |
ZA200806949B (en) | Medicinal formulation for the treatment for hepatitis C | |
EP2099303A4 (en) | THERAPEUTIC COMPOSITIONS ON TETRAHYDROISOCHINOLINE BASE FOR CANCER THERAPY | |
GB0815179D0 (en) | Medication and treatment for infection | |
GB0610376D0 (en) | Therapeutic treatment | |
HK1217641A1 (zh) | 用於治療慢性感染的製劑和方法 | |
GB0600817D0 (en) | Medical treatment | |
ZA201001779B (en) | Compositions and methods for treating collagen-mediated diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed |